Business

Notification of Preliminary Results

Notification of Preliminary Results.

articleFutura Medical PlcFebruary 15, 20185/company/futura-medical-plc/news/notification-of-preliminary-results-17
Notification of Preliminary Results

About this update from Futura Medical Plc

[{"type":"text","content":"\n \nRNS Number : 9255E Futura Medical PLC 15 February 2018  \n\n\n\n\n\nFor immediate release \n\n\n15 February  2018\n\n\n\n\n \n \n \nFutura Medical plc\n(\"Futura\" or \"the Company\")\n \nNotification of Preliminary Results\n \nFutura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its preliminary results for the year ended 31 December 2017 on Wednesday 14 March 2018.\n \nA briefing for analysts will be held at 11.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.\n \nThere will be a webcast of the analyst presentation. If you would like to listen to the webcast, please log on to the following web address approximately 5 minutes before 11.00am on the day of results:\nhttp://vm.buchanan.uk.com/2018/futuramedical140318/registration.htm\n \nA recording of the webcast will also be made available at www.futuramedical.com following the results meeting.\n \nFor more information, or to register attendance, contact Buchanan on 020 7466 5000.\n \n \n \nFor any further information please contact:\n \n \n\n\n\n\nFutura Medical plc\n\n\n \n\n\n\n\nJames Barder, Chief Executive\n \n\n\nTel: +44 (0)1483 685 670\n\n\n\n\nmail to: [email protected]\n\n\nwww.futuramedical.com\n\n\n\n\n \n \n\n\n \n\n\n\n\nN+1 Singer (Nominated Adviser and Broker)\n\n\n \n\n\n\n\nAubrey Powell / Liz Yong \n \n\n\nTel:+44 (0) 20 7496 3000\n\n\n\n\n \n\n\n \n\n\n\n\nFor media enquiries please contact:\n \n\n\n \n\n\n\n\nBuchanan\n\n\n \n\n\n\n\nMark Court / Sophie Wills / Stephanie Watson\n\n\nTel: +44 (0)20 7466 5000\n\n\n\n\n \nNotes to Editors\n \nFutura Medical plc\n \nFutura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.\n \nFutura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.\n \nwww.futuramedical.com \n\nThis information is provided by RNSThe company news service from the London Stock Exchange  END &nb...

More updates from Futura Medical Plc